Levinstein M, Budinich R, Bonaventura J, Schatzberg A, Zarate Jr C, Michaelides M
Am J Psychiatry. 2025; 182(3):247-258.
PMID: 39810555
PMC: 11872000.
DOI: 10.1176/appi.ajp.20240378.
Boikov S, Karelina T, Sibarov D, Antonov S
Front Pharmacol. 2024; 15:1432718.
PMID: 39156114
PMC: 11327140.
DOI: 10.3389/fphar.2024.1432718.
Boikov S, Sibarov D, Antonov S
Front Cell Neurosci. 2022; 16:946426.
PMID: 35860312
PMC: 9289099.
DOI: 10.3389/fncel.2022.946426.
Stepanenko Y, Sibarov D, Shestakova N, Antonov S
Front Pharmacol. 2022; 12:815368.
PMID: 35237149
PMC: 8882908.
DOI: 10.3389/fphar.2021.815368.
Kumamoto E
Pharmaceuticals (Basel). 2020; 13(4).
PMID: 32260535
PMC: 7243109.
DOI: 10.3390/ph13040062.
Involvement of glutamate and serotonin transmitter systems in male sex determination in Daphnia pulex.
Camp A, Yun J, Chambers S, Haeba M, LeBlanc G
J Insect Physiol. 2020; 121:104015.
PMID: 31930975
PMC: 7098118.
DOI: 10.1016/j.jinsphys.2020.104015.
Psychotropic Drugs for the Management of Chronic Pain and Itch.
Belinskaia D, Belinskaia M, Barygin O, Vanchakova N, Shestakova N
Pharmaceuticals (Basel). 2019; 12(2).
PMID: 31238561
PMC: 6631469.
DOI: 10.3390/ph12020099.
Ketamine and phencyclidine: the good, the bad and the unexpected.
Lodge D, Mercier M
Br J Pharmacol. 2015; 172(17):4254-76.
PMID: 26075331
PMC: 4556466.
DOI: 10.1111/bph.13222.
Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
Cooke J, Cavender H, Lima H, Grover L
Psychopharmacology (Berl). 2014; 231(23):4429-41.
PMID: 24781518
PMC: 4214920.
DOI: 10.1007/s00213-014-3587-1.
Milnacipran inhibits glutamatergic N-methyl-D-aspartate receptor activity in spinal dorsal horn neurons.
Kohno T, Kimura M, Sasaki M, Obata H, Amaya F, Saito S
Mol Pain. 2012; 8:45.
PMID: 22716121
PMC: 3407012.
DOI: 10.1186/1744-8069-8-45.
Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.
Kobayashi T, Washiyama K, Ikeda K
PLoS One. 2011; 6(12):e28208.
PMID: 22164246
PMC: 3229538.
DOI: 10.1371/journal.pone.0028208.
Effect of glibenclamide on antinociceptive effects of antidepressants of different classes.
Hajhashemi V, Amin B
Clinics (Sao Paulo). 2011; 66(2):321-5.
PMID: 21484053
PMC: 3059867.
DOI: 10.1590/s1807-59322011000200023.
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations.
Ludolph A, Udvardi P, Schaz U, Henes C, Adolph O, Weigt H
Br J Pharmacol. 2010; 160(2):283-91.
PMID: 20423340
PMC: 2874851.
DOI: 10.1111/j.1476-5381.2010.00707.x.
Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.
Aboukhatwa M, Dosanjh L, Luo Y
Mol Neurodegener. 2010; 5:10.
PMID: 20226030
PMC: 2845130.
DOI: 10.1186/1750-1326-5-10.
Antidepressant interactions with the NMDA NR1-1b subunit.
Raabe R, Gentile L
J Biophys. 2010; 2008:474205.
PMID: 20107576
PMC: 2809336.
DOI: 10.1155/2008/474205.
Ketamine and the next generation of antidepressants with a rapid onset of action.
Machado-Vieira R, Salvadore G, Diazgranados N, Zarate Jr C
Pharmacol Ther. 2009; 123(2):143-50.
PMID: 19397926
PMC: 2726824.
DOI: 10.1016/j.pharmthera.2009.02.010.
The effects of chronic versus acute desipramine on nicotine withdrawal and nicotine self-administration in the rat.
Paterson N, Semenova S, Markou A
Psychopharmacology (Berl). 2008; 198(3):351-62.
PMID: 18438738
PMC: 2452988.
DOI: 10.1007/s00213-008-1144-5.
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.
Sanacora G, Zarate C, Krystal J, Manji H
Nat Rev Drug Discov. 2008; 7(5):426-37.
PMID: 18425072
PMC: 2715836.
DOI: 10.1038/nrd2462.
Modulation of ligand-gated ion channels by antidepressants and antipsychotics.
Rammes G, Rupprecht R
Mol Neurobiol. 2007; 35(2):160-74.
PMID: 17917105
DOI: 10.1007/s12035-007-0006-1.
Animal models and treatments for addiction and depression co-morbidity.
Paterson N, Markou A
Neurotox Res. 2007; 11(1):1-32.
PMID: 17449445
DOI: 10.1007/BF03033479.